Valeant to Acquire Eyetech

By Bizclik Editor

 

Valeant Pharmaceuticals announced today its agreement to acquire Eyetech, a US based ophthalmic biotechnology company. Expected to close this week, the acquisition will allow Valeant access to the knowledge Eyetech has on the treatment of sight-threatening diseases of the retina.

Eyetech is currently marketing Macugen in the US, the “first anti-VEGF inhibitor approved for the treatment of wet age-related macular degeneration.” Macugen, administered every six weeks by intravitreal injection, treats macular degeneration by binding to the vascular endothelial growth fact (VEGF). Sales of Macugen outside of the US are currently operated by Pfizer.

"This acquisition of Eyetech will fit nicely with our existing ophthalmology business, which includes a preservative free Timoptic in Ocudose and Lacrisert, products obtained through our acquisition of Aton in 2010," stated J. Michael Pearson, chairman and chief executive officer.  "The ophthalmology market has similar characteristics to the dermatology space and is a natural extension of our development capabilities.  We will continue to look for future opportunities to acquire additional products and gain important critical mass in this specialty space."

 

SEE RELATED STORIES FROM THE WDM CONTENT NETWORK:

Click here to read the latest edition of Business Review Canada

The purchase price is undisclosed, but Valeant did explain that it was for an “upfront payment as well as potential future milestones that total significantly less than two times sales”.

It is clear Valeant has no plans in stopping its prescription solution growth that it has been pursuing through acquisition since 2010. Valeant has been able to become a leader in the pharmaceutical world due to its already great pharmaceutical offerings and its purchase of multiple drug companies such as iNova and Dermik. 

Share

Featured Articles

JPMorgan Chase: Committed to supporting the next generation

JPMorgan has unveiled a host of new and expanded philanthropic activities totalling US$3.5 million to support the development of apprenticeship programmes

How efficient digital ecosystems became business critical

During this unprecedented era of rapid digital transformation, establishing a well-functioning ecosystem stands to benefit both employees and customers

Mastercard: Supporting clients at a time of rapid evolution

Mastercard has announced a significant expansion of its consulting business with the launch of new practices dedicated to both AI and economics

Why Ceridian has boldly rebranded to Dayforce

Human Capital

McKinsey’s eight lessons in leadership for aspiring CEOs

Leadership & Strategy

KPMG: The biggest challenges facing global CEOs in 2023

Leadership & Strategy